Zila To Present at Roth 2007 New York Conference
August 28 2007 - 9:00AM
PR Newswire (US)
PHOENIX, Aug. 28 /PRNewswire-FirstCall/ -- Zila, Inc. (NASDAQ:ZILA)
today announced that Frank J. Bellizzi, DMD, president of Zila
Pharmaceuticals, will present a company overview at the Roth 2007
New York Conference on Wednesday, September 5, 2007 at 4:30 p.m. ET
at The Westin New York Hotel at Times Square. Interested parties
can listen to the presentation through a live webcast at the Zila
Web site, http://www.zila.com/. Listeners are encouraged to visit
the Web site at least 15 minutes prior to the start of the
scheduled presentation to register, download and install any
necessary audio software. For those unable to listen to the live
webcast, the presentation will be archived on the same Web site for
approximately 90 days. About Zila, Inc. Zila, Inc., headquartered
in Phoenix, is an oral cancer screening company focused on the
prevention and treatment of oral disease. Zila is dedicated to
establishing ViziLite(R) Plus as the new standard of care for the
early detection of oral abnormalities that could lead to cancer,
with an initial focus on the dental market through Pro-Dentec(R), a
leading designer, manufacturer and marketer of Soft Tissue
Management (STM(R)) products. Sold exclusively and directly to
dental professionals, Pro-Dentec's core products include the
Rota-dent(R) Professional Powered Brush, the Pro- Select3(R)
Piezo-Ultrasonic Scaler System and a suite of pharmaceutical STM(R)
products for both in-office and home-care use. For more information
about Zila, visit http://www.zila.com/. DATASOURCE: Zila, Inc.
CONTACT: Robert Jaffe of PondelWilkinson Inc. for Zila, Inc.,
+1-310-279-5969 Web site: http://www.zila.com/
Copyright
Zila (NASDAQ:ZILA)
Historical Stock Chart
From May 2024 to Jun 2024
Zila (NASDAQ:ZILA)
Historical Stock Chart
From Jun 2023 to Jun 2024